<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02861105</url>
  </required_header>
  <id_info>
    <org_study_id>ASU-OG-333</org_study_id>
    <nct_id>NCT02861105</nct_id>
  </id_info>
  <brief_title>The Effect of LMWH on ICSI in Patients With Unexplained Infertility and Negative Immunological Markers</brief_title>
  <official_title>The Effect of LMWH on ICSI Outcome in Patients With Unexplained Infertility and Negative Immunological Markers; a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the efficacy of LMWH treatment in women with
      unexplained infertility and negative immunological markers undergoing ICSI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion criteria:

        1. patients undergoing 1st trial ICSI

        2. unexplained infertility

        3. negative immunological markers including ACL abs, LAC, ANA, ATA, AnitdsDNA

      Exclusion criteria:

        1. previous IVF/ICSI

        2. Any cause of infertility

        3. Suspected and/or unexpected poor response during ovulation induction

        4. positive immunological markers

        5. Age &gt; 40 years.

      All participants will undergo IVF/ICSI cycle using the Long luteal phase protocol. the dose
      of gonadotropins will be calculated according to patient age and BMI. All patients will have
      2-3 embryos transferred at D5 according to their age. the primary outcome will be LBR.
      secondary outcomes will include biochemical pregnancy rate and clinical pregnancy rate.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Live birth Rate</measure>
    <time_frame>at delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Pregnancy Rate</measure>
    <time_frame>at 7 weeks of gestation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical Pregnancy Rate</measure>
    <time_frame>14 days after embryo transfer</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">716</enrollment>
  <condition>Unexplained Infertility</condition>
  <arm_group>
    <arm_group_label>LMWH supplementation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>40 mg of enoxaparin injected subcutaneously every 24 hours starting the day of ovum pick-up to the documentation of fetal life by ultrasound at 7 weeks of gestation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.9% saline solution</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.9% saline injected subcutaneously every 24 hours starting the day of ovum pick-up to the documentation of fetal life by ultrasound at 7 weeks of gestation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LMWH</intervention_name>
    <description>LMWH will be given on daily basis subcutaneously every 24 hours starting one day after ovum pick up till documentation of fetal life by ultrasound at 7 weeks.</description>
    <arm_group_label>LMWH supplementation</arm_group_label>
    <other_name>Clexane</other_name>
    <other_name>Enoxaparin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>0.9% saline solution</intervention_name>
    <description>0.9% saline solution will be given subcutaneously every 24 hours starting one day after ovum pick up till documentation of fetal life by ultrasound at 7 weeks.</description>
    <arm_group_label>0.9% saline solution</arm_group_label>
    <other_name>0.9% sodium chloride solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age less than 38 years

          -  at least 12 months of infertility

          -  women with unexplained infertility

        Exclusion Criteria:

          -  age more than or equals 38 years

          -  serum AMH level less than or equals 1 ng/ml

          -  patients of anticoagulant therapy

          -  immune-compromised patients

          -  patients with contraindications to low molecular weight heparin

          -  positive immunological markers

          -  patients with other than unexplained infertility

          -  male factor infertility

          -  refusal of participation

          -  patients with unexpected poor or over response during induction of ovulation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mostafa F Gomaa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2016</study_first_submitted>
  <study_first_submitted_qc>August 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2016</study_first_posted>
  <last_update_submitted>August 11, 2016</last_update_submitted>
  <last_update_submitted_qc>August 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Mostafa Fouad Gomaa</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Heparin, Low-Molecular-Weight</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

